LEMAITRE VASCULAR INC - Common Stock (LMAT)

Q2 2020 13F Holders as of 6/30/2020

Type / Class
Equity / Common Stock
Shares outstanding
22.5M
Number of holders
141
Total 13F shares, excl. options
16.8M
Shares change
-5.99K
Total reported value, excl. options
$445M
Value change
+$84.8K
Number of buys
64
Number of sells
-55
Price
$26.40

Significant Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q2 2020

150 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock as of Q2 2020.
LEMAITRE VASCULAR INC - Common Stock (LMAT) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 16.8M shares of 22.5M outstanding shares and own 74.93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.68M shares), Conestoga Capital Advisors, LLC (1.8M shares), VANGUARD GROUP INC (1.25M shares), GENEVA CAPITAL MANAGEMENT LLC (892K shares), DIMENSIONAL FUND ADVISORS LP (890K shares), STATE STREET CORP (726K shares), Copeland Capital Management, LLC (666K shares), Ranger Investment Management, L.P. (657K shares), PRINCIPAL FINANCIAL GROUP INC (508K shares), and Summit Creek Advisors LLC (319K shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.